Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oestrogen receptor 1 mRNA is a prognostic factor in ovarian cancer patients treated with neo-adjuvant chemotherapy: determination by array and kinetic PCR in fresh tissue biopsies.
Zamagni C, Wirtz RM, De Iaco P, Rosati M, Veltrup E, Rosati F, Capizzi E, Cacciari N, Alboni C, Bernardi A, Massari F, Quercia S, D'Errico Grigioni A, Dietel M, Sehouli J, Denkert C, Martoni AA. Zamagni C, et al. Among authors: quercia s. Endocr Relat Cancer. 2009 Dec;16(4):1241-9. doi: 10.1677/ERC-08-0342. Epub 2009 Sep 11. Endocr Relat Cancer. 2009. PMID: 19749010
Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy.
Martoni AA, Zamagni C, Quercia S, Rosati M, Cacciari N, Bernardi A, Musto A, Fanti S, Santini D, Taffurelli M. Martoni AA, et al. Among authors: quercia s. Cancer. 2010 Feb 15;116(4):805-13. doi: 10.1002/cncr.24820. Cancer. 2010. PMID: 20052718 Free article.
Potential utility of early metabolic response by 18F-2-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in a selected group of breast cancer patients receiving preoperative chemotherapy.
Zucchini G, Quercia S, Zamagni C, Santini D, Taffurelli M, Fanti S, Martoni AA. Zucchini G, et al. Among authors: quercia s. Eur J Cancer. 2013 May;49(7):1539-45. doi: 10.1016/j.ejca.2012.12.024. Epub 2013 Jan 29. Eur J Cancer. 2013. PMID: 23369464
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: a prospective female cohort study on >2000 ECGs.
Diemberger I, Massaro G, Cubelli M, Rubino D, Quercia S, Martignani C, Ziacchi M, Biffi M, Bernardi A, Cacciari N, Zamagni C, Boriani G. Diemberger I, et al. Among authors: quercia s. Eur J Clin Pharmacol. 2015 Aug;71(8):1001-9. doi: 10.1007/s00228-015-1874-3. Epub 2015 Jun 2. Eur J Clin Pharmacol. 2015. PMID: 26028320
Reply to "¹⁸F-2-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography in predicting pathologic complete response after neoadjuvant chemotherapy: the early metabolic response is the answer".
Zucchini G, Quercia S, Zamagni C, Santini D, Taffurelli M, Fanti S, Martoni AA. Zucchini G, et al. Among authors: quercia s. Eur J Cancer. 2013 Nov;49(16):3575-6. doi: 10.1016/j.ejca.2013.08.010. Epub 2013 Sep 4. Eur J Cancer. 2013. PMID: 24011537 No abstract available.
33 results